Science & Technology Almanac

By Lynn Lauerman | Go to book overview
Save to active project


Health & Medicine



Developments in AIDS Vaccines

In 2001, promising new developments in AIDS vaccine research were announced at scientific meetings in the United States, including the 8th Conference on Retroviruses and Opportunistic Infections held in Chicago, Illinois, in February, and the AIDS Vaccine 2001 Conference held in Philadelphia, Pennsylvania, in September.

As the number of people with HIV infection and/or AIDS increases and as little progress in drug treatments for AIDS has been made in recent years, many researchers have turned to developing vaccines against the disease, which has been aided by a large increase in funding for AIDS vaccine research from the U.S. National Institutes of Health, as well as from nonprofit organizations and industry.

Some of the new vaccines, including two presently undergoing clinical trials in humans, are based on a protein called gp 120. This protein occurs on the surface of the AIDS virus and binds to CD4 receptors on the surface of white blood cells, which the AIDS virus infects and destroys. Researchers hope that the vaccine will prime the immune system to destroy any AIDS viruses in the blood before they can infect white blood cells.

Other vaccines under development are aimed at boosting cell-mediated immunity, which involves killing cells that have already been infected. These vaccines are made from a vector, such as a harmless virus, bacterium, or loop of DNA, which has had specific AIDS genes added to it. The vector infects white blood cells and produces AIDS proteins, which stimulate certain cytotoxic T cells to kill infected cells. It is then hoped that any subsequent infection would be wiped out by the primed cytotoxic T cells.

Encouraging news for AIDS vaccine research also came from the pharmaceutical company Merck & Co. of Whitehouse Station, New Jersey, at a conference in Keystone, Colorado, held in April 2001. The company announced that they are testing five AIDS vaccines in over 100 monkeys. The most successful vaccines are now being tested in humans, but it may be several years before researchers know if they are effective in people.


Health Implications of Ground Zero

After the terrorist attack on the World Trade Center (WTC) in New York City on September 11, 2001, recovery workers and residents in lower Manhattan raised health concerns about dangerous substances released into the air. In addition to the toxic chemicals from the burning debris of the World Trade Center, other potentially poisonous substances, including asbestos, fiberglass, and coolant from air-conditioning units, were released into the air when the WTC collapsed. After the attack, an increase in respiratory disorders was reported among firefighters at the WTC. Recovery workers and residents are now worried about long-term health implications.

The Environmental Protection Agency (EPA) has been monitoring the levels of dangerous chemicals at the site of the WTC, now known as Ground Zero. The EPA found that the levels of highly toxic dioxin and benzene exceeded permissible levels laid down by the Occupational Safety and Health Administration. Levels of asbestos were up to three times the acceptable limit in 34 of 128 samples of debris.

The New York City Health Department warned that the dust, ash, and soot from burning materials could worsen existing breathing problems. They also informed


Notes for this page

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Cite this page

Cited page

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited page

Bookmark this page
Science & Technology Almanac


Text size Smaller Larger
Search within

Search within this book

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen
/ 514

matching results for page

Cited passage

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?